Newsroom Archive
 

March 12, 2020
 
Bioness Announces First United Kingdom Implant for StimRouter Neuromodulation System at Leeds Teaching Hospitals NHS Trust

January 20, 2020
 
Bioness Announces StimRouter Milestones at 2020 North American Neuromodulation Society’s Annual Meeting

January 16, 2020
 
Bioness StimRouter® Neuromodulation System Receives CE Mark Approval for the Treatment of Fecal Incontinence

December 19, 2019
 
Bioness Introduces Improved Training Platform for Surgeons Expanding Their Practice to Include the StimRouter Peripheral Nerve Stimulator

November 13, 2019
 
Published Clinical Success for Bioness StimRouter Peripheral Nerve Stimulator

September 4, 2019
 
Bioness Announces Preliminary European Post-Approval Results of StimRouter® Neuromodulation System for the Treatment of Overactive Bladder at the 49th International Continence Society Annual Meeting

May 13, 2019
 
Bioness Announces First Australian Implant of StimRouter® Neuromodulation System at Nambour Selangor Private Hospital

February 18, 2019
 
Bioness StimRouter® Neuromodulation System Receives CE Mark Approval for the Treatment of Overactive Bladder (OAB)

February 18, 2019
 
Bioness StimRouter® Neuromodulation System Receives European CE Mark Approval for the Treatment of Overactive Bladder (OAB)

January 17, 2019
 
Bioness to Sponsor Educational Session on Peripheral Nerve Stimulation at 2019 North American Neuromodulation Society’s Annual Meeting

January 14, 2019
 
Bioness Introduces First Peripheral Nerve Stimulation Registry with its StimRouter™ Neuromodulation System

June 11, 2018
 
Bioness Announces First Canadian Implants of StimRouter® Neuromodulation System at Women’s College Hospital

March 7, 2018
 
New Medical Policy Makes the Bioness StimRouter® Neuromodulation System a Covered Benefit for Highmark Blue Cross Blue Shield Policy Holders

February 20, 2018
 
Bioness to Exhibit Updated Rehabilitation Products at the 2018 American Physical Therapy Association’s Combined Sections Meeting

January 29, 2018
 
Bioness Receives Health Canada Approval for StimRouter Neuromodulation System

January 11, 2018
 
Clinical Data on the Bioness Stimrouter Neuromodulation System to be Presented at the 2018 North American Neuromodulation Society’s Annual Meeting

December 7, 2017
 
Bioness StimRouter® Neuromodulation System Eligible for Increased Medicare Reimbursements

October 12, 2017
 
Bioness to Showcase Complete Product Portfolio at the American Academy of Physical Medicine and Rehabilitation Annual Assembly

March 30, 2017
 
Bioness to Exhibit at Annual American Occupational Therapy Association Conference and Centennial Celebration

January 20, 2017
 
Bioness StimRouter Neuromodulation System Clinical Data Presented at the 2017 North American Neuromodulation Societys Annual Meeting

September 28, 2016
 
Bioness Welcomes Eric Grigsby (MD, MBA) As Chief Medical Officer

September 07, 2016
 
Improving the Lives of Patients, Bioness’ StimRouter Neuromodulation System Currently Being Implanted to Manage Chronic Pain

February 01, 2016
 
Bioness Announces the Publication of StimRouter Neuromodulation System Clinical Trial

September 16, 2015
 
Bioness Announces first commercial procedure of StimRouter Neuromodulation System

July 14, 2015
 
Bioness Announces a notification for allowance from the U.S. patent and trademark office for StimRouter Neuromodulation System

June 8, 2015
 
Bioness Announces the commercial launch of StimRouter Neuromodulation System at the International Neuromodulation Society World Congress

March 26, 2015
 
Bioness initiates pilot study of StimRouter Neuromodulation System for overactive bladder (OAB)

February 23, 2015
 
Bioness Announces FDA 510(k) clearance of StimRouter System; A novel, implantable neuromodulation device designed to treat chronic peripheral pain